| Shanghai Jiao Tong University | |
|---|---|
| Location | Shanghai, China |
| Type | Public Research University |
| Founded | 1896 |
| Website | www.sjtu.edu.cn |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, Neuroimaging, Stem Cell Therapy, Biomarkers |
| Rankings | C9 League, Top 100 globally |
Shanghai Jiao Tong University (SJTU) is one of China's oldest, most prestigious, and largest research universities, located in Shanghai. Founded in 1896 as Nanyang Public School, it has grown into a comprehensive university with strengths in engineering, medicine, science, and humanities. SJTU has rapidly emerged as a major center for biomedical research and neuroscience, with state-of-the-art facilities and internationally recognized research programs[@sjtu-home].
SJTU is a member of China's "C9 League," the Chinese equivalent of the Ivy League, and consistently ranks among the top 100 universities globally. The university serves approximately 30,000 students across multiple campuses in Shanghai and has established itself as a leading institution for neurodegenerative disease research in Asia.
SJTU traces its origins to 1896 when it was established as Nanyang Public School by Sheng Xianhuai, a prominent Chinese educator. The institution was renamed Shanghai Jiao Tong University in 1921, with "Jiao Tong" meaning "transport" or "communication" in Chinese, reflecting its original focus on engineering and technology.
Throughout its history, SJTU has pioneered Chinese higher education:
SJTU operates several campuses across Shanghai:
The historic main campus located in downtown Shanghai, housing the main administrative offices, School of Medicine, and undergraduate programs. The campus features colonial-era architecture and proximity to Ruijin Hospital.
The modern campus for science, engineering, and technology programs. This campus houses the School of Biomedical Engineering, the Institute of Neuroscience, and most research laboratories. It spans over 3,000 mu (approximately 500 acres) of land.
The medical campus adjacent to Ruijin Hospital, dedicated to clinical research and medical education. This campus includes the Shanghai Institute for Biological Sciences and the neuroscience clinical research center.
The newest campus for emerging disciplines, including artificial intelligence, materials science, and marine engineering.
The School of Biomedical Engineering represents one of China's leading biomedical engineering programs, with extensive research in[@sjtu-med]:
Neuroengineering and Neural Interfaces: Development of brain-machine interfaces, neural probes, and neurostimulation devices. Research includes high-density electrode arrays for neural recording and closed-loop stimulation systems for Parkinson's disease treatment.
Advanced Neuroimaging Techniques: State-of-the-art MRI (including 7T), PET, fNIRS, and computed tomography for studying brain structure and function. The center collaborates with hospitals across Shanghai for clinical imaging studies.
Computational Neuroscience and Brain Modeling: Development of computational models of neural circuits, brain network analysis, and simulation of neurodegeneration processes. Projects include large-scale brain network modeling and AI-driven diagnostic tools.
Medical Robotics and Neurorehabilitation: Design of robotic systems for stroke rehabilitation, assistive devices for patients with motor impairments, and intelligent prosthetics.
Biosensors and Diagnostics: Development of point-of-care diagnostic devices for neurodegenerative disease biomarkers, including blood-based tests for Alzheimer's disease and Parkinson's disease.
The Institute conducts fundamental neuroscience research with particular focus on[@sjtu-neuro]:
Molecular Mechanisms of Neurodegeneration
Research investigates the molecular pathways underlying neuronal death in Alzheimer's and Parkinson's disease. Studies include:
Studies by Wang et al. (2024) explored neurodegeneration mechanisms specific to Chinese populations, highlighting genetic and environmental factors unique to Asian populations[@wang2024]. Xia et al. (2023) investigated amyloid-beta metabolism and tau pathology in Asian populations, finding distinct patterns compared to Western cohorts[@xia2023].
Synaptic Physiology and Plasticity
The synapse is a primary target in neurodegeneration. Research examines:
Liu et al. (2024) published work on alpha-synuclein aggregation in Parkinson's disease models, demonstrating how synuclein pathology disrupts synaptic function[@liu2024].
Neural Circuit Formation and Function
Understanding neural circuits provides insight into disease mechanisms:
Stem Cell Biology and Regenerative Approaches
Research on stem cell therapies for neurodegenerative diseases includes:
Su et al. (2023) reviewed stem cell therapy approaches for neurodegenerative diseases, highlighting progress and challenges in translational applications[@su2023].
Ruijin Hospital, affiliated with SJTU School of Medicine, houses a comprehensive neuroscience center with active clinical research programs[@sjtu-med]:
Alzheimer's Disease Clinical Trials
Parkinson's Disease Deep Brain Stimulation
Xu et al. (2023) published research on deep brain stimulation for Parkinson's disease in Asian populations, demonstrating efficacy and optimal stimulation parameters[@xu2023].
Stroke Rehabilitation Programs
Cognitive Disorders Clinic
SJTU researchers focus on multiple cutting-edge areas of neurodegenerative disease research:
Research programs encompass the full spectrum of Alzheimer's disease research:
Biomarker Discovery
Zhang et al. (2023) investigated neuroinflammation as a critical component of Alzheimer's disease progression, demonstrating that inflammatory markers predict cognitive decline[@zhang2023]. Feng et al. (2024) developed novel blood-based biomarkers for Alzheimer's disease diagnosis, achieving high sensitivity and specificity in Chinese cohorts[@feng2024].
Neuroimaging
Tang et al. (2024) developed neuroimaging biomarkers for early Alzheimer's disease detection, using machine learning to identify subtle changes in brain structure and connectivity[@tang2024]. Liu et al. (2023) conducted studies on tau PET imaging for early dementia detection[@liu2023].
Therapeutic Strategies
Research includes drug discovery, gene therapy approaches, and non-pharmacological interventions. Yang et al. (2023) explored neuroprotective strategies in animal models of neurodegeneration[@yang2023].
Genetics
Wu et al. (2023) investigated apolipoprotein E allele frequencies in Chinese Alzheimer's disease patients, finding distinct patterns compared to Western populations[@wu2023].
Research programs address both motor and non-motor symptoms:
Molecular Mechanisms
Chen et al. (2024) identified LRRK2 mutations in Chinese Parkinson's disease patients, characterizing the prevalence and clinical features of LRRK2-associated parkinsonism[@chen2024]. Liu et al. (2024) studied alpha-synuclein aggregation mechanisms in detail.
Mitochondrial Dysfunction
Wang et al. (2023) investigated mitochondrial dysfunction as a central mechanism in neurodegeneration, identifying potential therapeutic targets[@wang2023].
Autophagy and Protein Clearance
Zhao et al. (2024) explored the autophagy-lysosome pathway in protein clearance, demonstrating how impaired autophagy contributes to protein aggregation[@zhao2024].
Synaptic Dysfunction
Zhou et al. (2024) examined synaptic dysfunction in Parkinson's disease models, linking molecular changes to behavioral deficits[@zhou2024].
Gut-Brain Axis
Guo et al. (2024) investigated the gut-brain axis in Parkinson's disease pathogenesis, identifying potential biomarkers and therapeutic targets in the gut microbiome[@guo2024].
SJTU's neuroimaging research includes:
Research programs explore:
Programs include:
A major focus area examining:
Zhang et al. (2023) demonstrated that neuroinflammation is a critical driver of Alzheimer's disease progression[@zhang2023].
Hu et al. (2023) studied calcium dysregulation in neuronal death, identifying therapeutic targets for neuroprotection[@hu2023].
Gong et al. (2024) investigated RNA metabolism alterations in neurodegeneration, demonstrating how RNA-binding proteins contribute to disease pathogenesis[@gong2024].
Pan et al. (2023) explored epigenetic modifications in neurodegeneration, including DNA methylation and histone changes in disease states[@pan2023].
| Researcher | Position | Focus Areas |
|---|---|---|
| Prof. Min Wang | Director, Institute of Neuroscience | Molecular mechanisms of neurodegeneration, protein aggregation |
| Prof. Hong Xia | School of Medicine | Neuroimaging, Alzheimer's disease biomarkers |
| Prof. Li Liu | School of Biomedical Engineering | Neuroengineering, brain-machine interfaces |
| Prof. Wei Chen | Ruijin Hospital Neurology | Parkinson's disease, movement disorders |
| Prof. Yan Zhang | Institute of Neuroscience | Neuroinflammation, glial biology |
SJTU provides world-class research infrastructure:
| Disease | Research Focus | Active Projects |
|---|---|---|
| Alzheimer's Disease | Biomarkers, imaging, clinical trials, therapy development | 25+ |
| Parkinson's Disease | Motor symptoms, non-motor symptoms, DBS, genetics | 20+ |
| Stroke | Rehabilitation, neural regeneration, translational research | 15+ |
| ALS | Mechanism research, clinical trials | 8+ |
| Huntington's Disease | Genetic models, therapeutic targets | 5+ |
SJTU maintains extensive international partnerships:
SJTU offers comprehensive neuroscience education:
SJTU's neuroscience research has significant impact:
SJTU continues to expand its neurodegeneration research program:
Shanghai Jiao Tong University has established itself as a leading institution for neurodegenerative disease research in China and Asia. Through its comprehensive research programs, state-of-the-art facilities, and international collaborations, SJTU contributes significantly to understanding the mechanisms of neurodegeneration and developing new therapies for Alzheimer's disease, Parkinson's disease, and related conditions.
The university's unique position in Shanghai, combined with its strong basic science and clinical research programs, positions it to make continued contributions to the global effort to understand and treat neurodegenerative diseases. Particularly important is the focus on Asian populations, whose genetic and environmental factors may differ from Western cohorts.
SJTU participates in China's Brain Research Initiative, a national program aimed at mapping neural circuits and understanding brain function[@sjtu-neuro]. This initiative coordinates research efforts across multiple Chinese institutions and fosters collaboration between basic neuroscientists and clinical researchers.
SJTU leads an international consortium focused on comparative studies of neurodegeneration across ethnically diverse populations. This research examines how genetic background, lifestyle factors, and environmental exposures influence disease onset, progression, and treatment response.
The university manages multiple collaborative research grants:
Ruijin Hospital's Neurology Department conducts extensive clinical research in neurodegenerative diseases[@sjtu-med]:
Patient Cohorts
Clinical Trial Infrastructure
Collaborating with the Shanghai Mental Health Center enables research on the psychiatric aspects of neurodegenerative diseases, including depression, anxiety, and psychosis in Alzheimer's and Parkinson's disease patients.
SJTU's engineering programs contribute to technology development for neurodegeneration research:
Neural Recording Devices
Stimulation Technologies
The university leverages AI for:
SJTU trains numerous graduate students and postdoctoral researchers in neurodegeneration research:
Annual Enrollment
International Exchange
The university engages in public education about neurodegenerative diseases:
SJTU researchers have received numerous awards for neurodegeneration research:
Despite progress, several research gaps remain:
Future research priorities include: